Presentation Title: Effect of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Plasma Lipidomic Profiles in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Speaker: Sarah Browne, M.D., Vice President, Clinical Development, Altimmune

Format: Fireside Chat

Available for 1x1 meetings

Format: Fireside Chat

Format: Fireside Chat

Presenters: Vipin Garg, Ph.D., Chief Executive Officer and Scott Harris, M.D., Chief Medical Officer

Presentation Title: Unlocking Glucagon Biology to Overcome Fibrosis in MASH

Speaker: M. Scott Harris, M.D., Chief Medical Officer, Altimmune, Inc.

Presentation Title: Pemvidutide preserves lean body mass during weight loss in patients with overweight and obesity: results of a phase 2, MRI-based body composition sub-study
(Session 038, Oral Presentation 557)

Speaker: Sarah Browne, M.D., Vice President, Clinical Development, Altimmune